ghk cu clinical trial 2024 Before vs. after 3 months of GHK-Cu peptide therapy 🪄 • smoother texture, more even tone, and skin that looks healthier overall. Small peptide, big difference 💙 12 Weeks of GHK-Cu Before

Sources: Eagleson KL, et al

These results suggested that -syn played a critical role in neuronal injury induced by chronic hypoxia

BPC-157, or Body Protecting Compound-157, is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from gastric juices.[1][2] It was first identified in the 1990s as part of research into cytoprotective agents that safeguard the gastrointestinal (GI) tract from damage.[3] Unlike many peptides, BPC-157 is highly stable in acidic environments, allowing for oral administration without significant degradation.[4] In compounding pharmacies, BPC-157 is often prepared as capsules, injectables, or topical formulations

Neuroprotection : Enhancing mitochondrial function and reducing free-radical production under hypoxic conditions ( 9, 10 )

Retatrutide: The Triple Agonist Revolution Retatrutide represents a groundbreaking approach to metabolic research as a first-in-class triple agonist medication developed by Eli Lilly